Literature DB >> 7889493

Elevated serum Lp(a) levels in the early and advanced stages of breast cancer.

E Kökoğlu1, I Karaarslan, H M Karaarslan, H Baloğlu.   

Abstract

Recently, lipoprotein (a) [Lp (a)] levels were found to be elevated in various types of cancer. This study was designed to evaluate the role of serum Lp (a) in early and advanced stages of breast cancer. Fasting venous blood samples were collected from 18 patients with Stage I, and 21 patients with Stage IV disease and were analysed for Lp (a). The results were compared with data from 22 healthy female controls. Patients with both Stage 1 and Stage IV disease had significantly higher (p < 0.001) Lp (a) concentrations than did healthy controls. Lp (a) was also found to be significantly elevated in Stage IV patients when compared with the Stage I group. Our data suggest that there is a highly significant association between Lp (a) and the presence and progression of breast cancer, and the serum Lp (a) determination may provide an aid in patients with breast cancer for both diagnostic purposes and the follow-up of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889493

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  4 in total

1.  Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

Authors:  Jessy John; Kurian Cherian; Thomas Abraham; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

2.  Low lipoprotein(a) concentration is associated with cancer and all-cause deaths: a population-based cohort study (the JMS cohort study).

Authors:  Motoji Sawabe; Noriko Tanaka; Makiko Naka Mieno; Shizukiyo Ishikawa; Kazunori Kayaba; Ken-ichi Nakahara; Satoru Matsushita
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

3.  Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers.

Authors:  Emilie Wong Chong; France-Hélène Joncas; Nabil G Seidah; Frédéric Calon; Caroline Diorio; Anne Gangloff
Journal:  BMC Cancer       Date:  2022-10-06       Impact factor: 4.638

4.  High Lipoprotein(a) Level Is Independently Associated with Adverse Clinicopathological Features in Patients with Prostate Cancer.

Authors:  Fang-Ming Wang; Yan Zhang
Journal:  Dis Markers       Date:  2019-11-22       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.